AIDeepTech
Designing pioneering vaccines and therapeutics with AI
Biologics make up 75% our portfolio, so to automate & accelerate the processes behind these will help us chase the miracles of science faster than ever before. Through the BioAIM project, we aim to do exactly that through dedicated AI tools to screen, optimize and design new large molecules.
Friday 16th
10:30 > 10:50
Sanofi
